Dapagliflozin
FARXIGA
SGLT2 Inhibitor (Antidiabetic)
NADAC/unit
$11.4772
No Shortage
Tier 1: 72.3%
vs. brand FARXIGA: Generic saves up to -15% per unit
Generic Manufacturers
ASTRAZENECA AB
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.